CGA
BIVI icon

Crescent Grove Advisors’s BioVie BIVI Stock Holding History

Crescent Grove Advisors’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-275
Closed -$11K – 279
2024
Q2 		$11K Hold
275
– – ﹤0.01% 275
2024
Q1 		$14.5K Buy
275
+80
+41% +$8.2K ﹤0.01% 298
2023
Q4 		$24.6K Buy
195
+85
+77% +$25.5K ﹤0.01% 282
2023
Q3 		$37.5K Buy
+110
New +$43K ﹤0.01% 268

Other funds holding BIVI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ZIG
Zullo Investment Group Scranton, Pennsylvania $264M AUM 26.77% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
UCMOK
United Capital Management of KS Salina, Kansas $660M AUM 50.85% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Crescent Grove Advisors's BIVI Position: Q3 2024 in Review

Crescent Grove Advisors sold out of BioVie (BIVI) in Q3 2024, closing a stake of 275 shares — an estimated $11K sold.

Crescent Grove Advisors first reported a position in BIVI in Q3 2023 and held it in 4 quarters. The position peaked at $37.5K in Q3 2023. 25 funds tracked by Wall St. Rank hold BIVI as of Q3 2024.

  • Crescent Grove Advisors reported no remaining BioVie position as of Q3 2024 after selling out during the quarter.
  • Crescent Grove Advisors sold 275 BioVie shares in Q3 2024, an estimated $11K.
  • Crescent Grove Advisors first reported a position in BioVie in Q3 2023 and held it in 4 quarters.
  • Crescent Grove Advisors's BioVie position peaked at $37.5K in Q3 2023.
  • 25 funds tracked by Wall St. Rank held BioVie as of Q3 2024.

Based on Crescent Grove Advisors's 13F filing for Q3 2024, filed 30 Oct 2024.